138 related articles for article (PubMed ID: 31679213)
1. Computational Biology: Toward Early Detection of Pancreatic Cancer.
Gupta MK; Sarojamma V; Reddy MR; Shaik JB; Vadde R
Crit Rev Oncog; 2019; 24(2):191-198. PubMed ID: 31679213
[TBL] [Abstract][Full Text] [Related]
2. Available technologies and clinical applications of targeted chemotherapy in pancreatic cancer.
Mukherjee I; Powell B; Parianos M; Downs D; Ross SB
Cancer Genet; 2016 Dec; 209(12):582-591. PubMed ID: 27613576
[TBL] [Abstract][Full Text] [Related]
3. RNA sequencing analyses reveal novel differentially expressed genes and pathways in pancreatic cancer.
Mao Y; Shen J; Lu Y; Lin K; Wang H; Li Y; Chang P; Walker MG; Li D
Oncotarget; 2017 Jun; 8(26):42537-42547. PubMed ID: 28418924
[TBL] [Abstract][Full Text] [Related]
4. Bioinformatics method to predict two regulation mechanism: TF-miRNA-mRNA and lncRNA-miRNA-mRNA in pancreatic cancer.
Ye S; Yang L; Zhao X; Song W; Wang W; Zheng S
Cell Biochem Biophys; 2014 Dec; 70(3):1849-58. PubMed ID: 25087086
[TBL] [Abstract][Full Text] [Related]
5. Identification of miRNA-mRNA crosstalk in pancreatic cancer by integrating transcriptome analysis.
Yang J; Zeng Y
Eur Rev Med Pharmacol Sci; 2015; 19(5):825-34. PubMed ID: 25807437
[TBL] [Abstract][Full Text] [Related]
6. Translation of recent advances and discoveries in molecular biology and immunology in the diagnosis and treatment of pancreatic cancer.
Albo D; Farrow B; Berger DH
Surg Oncol Clin N Am; 2008 Apr; 17(2):357-76, ix. PubMed ID: 18375357
[TBL] [Abstract][Full Text] [Related]
7. Circulating microRNAs as Potential Diagnostic, Prognostic and Therapeutic Targets in Pancreatic Cancer.
Ebrahimi S; Hosseini M; Ghasemi F; Shahidsales S; Maftouh M; Akbarzade H; Parizadeh SA; Hassanian SM; Avan A
Curr Pharm Des; 2016; 22(42):6444-6450. PubMed ID: 27539232
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic cancer stem cells: association with cell surface markers, prognosis, resistance, metastasis and treatment.
Fitzgerald TL; McCubrey JA
Adv Biol Regul; 2014 Sep; 56():45-50. PubMed ID: 24925031
[TBL] [Abstract][Full Text] [Related]
9. Current and Future Trends in Early Detection of Pancreatic Cancer: Molecular Targets and PET Probes.
Alauddin MM; De Palatis L
Curr Med Chem; 2015; 22(29):3370-89. PubMed ID: 26295468
[TBL] [Abstract][Full Text] [Related]
10. Targeting dynamics of subclones of GI, liver and pancreatic cancers.
Ziogas DE; Glantzounis G; Liakakos T; Roukos DH
Expert Rev Gastroenterol Hepatol; 2016 Jul; 10(7):773-6. PubMed ID: 27143511
[No Abstract] [Full Text] [Related]
11. Targeting notch to eradicate pancreatic cancer stem cells for cancer therapy.
Wang Z; Ahmad A; Li Y; Azmi AS; Miele L; Sarkar FH
Anticancer Res; 2011 Apr; 31(4):1105-13. PubMed ID: 21508353
[TBL] [Abstract][Full Text] [Related]
12. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.
Zhou X; Lu Z; Wang T; Huang Z; Zhu W; Miao Y
Gene; 2018 Oct; 673():181-193. PubMed ID: 29913239
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-gene signaling pathways in pancreatic cancer.
Drakaki A; Iliopoulos D
Biomed J; 2013; 36(5):200-8. PubMed ID: 24225187
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D and pancreatic cancer.
Barreto SG; Neale RE
Cancer Lett; 2015 Nov; 368(1):1-6. PubMed ID: 26276715
[TBL] [Abstract][Full Text] [Related]
15. A competing endogenous RNA network identifies novel mRNA, miRNA and lncRNA markers for the prognosis of diabetic pancreatic cancer.
Yao K; Wang Q; Jia J; Zhao H
Tumour Biol; 2017 Jun; 39(6):1010428317707882. PubMed ID: 28639886
[TBL] [Abstract][Full Text] [Related]
16. The underlying mechanisms of non-coding RNAs in the chemoresistance of pancreatic cancer.
Xiong G; Feng M; Yang G; Zheng S; Song X; Cao Z; You L; Zheng L; Hu Y; Zhang T; Zhao Y
Cancer Lett; 2017 Jul; 397():94-102. PubMed ID: 28254409
[TBL] [Abstract][Full Text] [Related]
17. Traditional Chinese medicine may be further explored as candidate drugs for pancreatic cancer: A review.
Gao Y; Chen S; Sun J; Su S; Yang D; Xiang L; Meng X
Phytother Res; 2021 Feb; 35(2):603-628. PubMed ID: 32965773
[TBL] [Abstract][Full Text] [Related]
18. miR-1247 is correlated with prognosis of pancreatic cancer and inhibits cell proliferation by targeting neuropilins.
Shi S; Lu Y; Qin Y; Li W; Cheng H; Xu Y; Xu J; Long J; Liu L; Liu C; Yu X
Curr Mol Med; 2014 Mar; 14(3):316-27. PubMed ID: 24588767
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes.
McGuigan A; Kelly P; Turkington RC; Jones C; Coleman HG; McCain RS
World J Gastroenterol; 2018 Nov; 24(43):4846-4861. PubMed ID: 30487695
[TBL] [Abstract][Full Text] [Related]
20. A new method for early detection of pancreatic cancer biomarkers: detection of microRNAs by nanochannels.
Xu J; Liao K; Fu Z; Xiong Z
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2634-2640. PubMed ID: 31220948
[No Abstract] [Full Text] [Related]
[Next] [New Search]
